We use cookies on our website. Some are necessary for the operation of the website. You can also allow cookies for statistical purposes. You can adjust the data protection settings or agree to all cookies directly.
Data Protection Declaration
Imprint
EMPERIE - European management platform for emerging and re-emerging infectious disease entities
Project
Project code: FLI-IVD-08-Ri-0061
Contract period: 01.05.2009
- 30.04.2014
Budget: 11,909,560 Euro
Purpose of research: Basic research
The EMPERIE (European Management Platform for Emerging and Re-emerging Infectious disease Entities) consortium has its roots in the lessons learned by the majority of the participating centres during the recent SARS and HPAI H5N1 outbreaks.
The mission of EMPERIE is to contribute to effectively countering the potential public health threat caused by new and emerging infectious diseases in Europe by establishing a powerful network capable of structural and systematic prediction, identification, modelling and surveillance of infectious diseases health threats and pathogens . In pursuit of this mission EMPERIE will establish a network of centres of excellence combining the expertise, techniques and resources necessary for effectively countering (re)-emerging infectious diseases.
We will establish common processes, procedures and communication channels in the network linked to relevant stakeholder organisations and local grass root sites to contribute to a structural and systematic prediction, identification, modelling and surveillance of (re-)emerging infectious disease health threats and pathogens. Our focus will be new zoonotic viruses that may cause epidemics and viruses already present but yet unrecognised- in humans.
Within this focus, we will attain proof of principle of the functioning of the network and the techniques, systems, procedures and resources in the following RNA viruses: Flaviviruses (e.g. Dengue, West-Nile virus), Alphaviruses (e.g. Chikungunya), Orthomyxoviruses (e.g. Influenza), Paramyxoviruses (e.g Henipah,) Coronaviruses, Bunyaviruses ( e.g. hantavirus) and Filoviruses.
Section overview
Subjects
- Biotechnology
Framework programme
Funding programme
Excutive institution
Participating institutions
- Rheinische Friedrich-Wilhelms University of Bonn
- FLI - Institute of Diagnostic Virology (FLI - IVD)
- University of Amsterdam (UVA)
- Institut Pasteur
- University of Cambridge
- University of Oxford
- University of Hong Kong (HKU)
- Imperial College London
- Hospital for Tropical Diseases (HTD)
- National Centre for Disease Control (NCDC)
- State Agency Council for Scientific Research (CSIC)
- Wellcome Trust Sanger Institute
- Viroclinics Biosciences B.V.
